MedPath

Aerobic Training in Pregnant Women With Gestational Diabetes and Chronic Hypertension

Not Applicable
Completed
Conditions
Gestational Diabetes Mellitus
Pregnancy
Chronic Hypertension in Obstetric Context
Registration Number
NCT01885234
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

The aim of the present study is verify glycated hemoglobin (HbA1c) and HOMA behavior in pregnant women with gestational diabetes or chronic hypertension after an aerobic training in cycle-ergometer. The sample is composed by 64 pregnant and sedentary women, 20 weeks' pregnant.

Two experimental groups (gestational diabetes and chronic hypertension, n = 16 each) will perform a low-intensity aerobic training in cycle-ergometer, three times/week, for 45 minutes each session. Two control groups (gestational diabetes and chronic hypertension, n = 16 each) will perform an unique session/week of relaxation and stretching.

Outcomes: first ventilatory threshold, HbA1c,HOMA, type of delivery, weight and height of the newborn.

Detailed Description

The statistical analysis will consist of:

* descriptive statistic;

* Levene's test

* Shapiro Wilk's normality test

* Parametric or non-parametric test

* a=0.05

* SPSS 17.0

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
9
Inclusion Criteria
  • age > 20 years;
  • gestational age between 20 and 27 weeks (date of the last period and confirmed by ultrasound);
  • Only one foetus in the womb;
  • Without orthopedic limitations;
  • Non-smoker;
  • Medical clearance for exercise
Exclusion Criteria
  • Pre-eclampsia;
  • fetal malformations;
  • Intrauterine fetal death

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
glycated hemoglobinday 1 and 10 weeks after training
Secondary Outcome Measures
NameTimeMethod
HOMAday 1 and 10 weeks after training

Trial Locations

Locations (1)

Hospital de Clínicas de Porto Alegre

🇧🇷

Porto Alegre, RS, Brazil

Hospital de Clínicas de Porto Alegre
🇧🇷Porto Alegre, RS, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.